Abstract
5518Background: AGO-OVAR 16 study investigated PZ, an oral multi-kinase inhibitor of VEGFR-1, -2, -3, PDGFR-α and -β and c-Kit. This study was designed to test efficacy, safety and tolerability of ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have